AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis

This study will evaluate the safety and efficacy of AGN-229666 for the treatment of seasonal or perennial allergic conjunctivitis.

Inclusion Criteria:

• Japanese patients living in Japan with allergic conjunctivitis with itching and redness
• Able and willing to discontinue wearing any contact lenses during the study period.

Exclusion Criteria:

• Eye surgical intervention and/or a history of refractive surgery within 6 months
• History of retinal detachment, diabetic retinopathy, or progressive retinal disease
• Presence of active eye infection (bacterial, viral, or fungal)
• History of an eye herpetic infection
• Use of corticosteroids within 6 months or anticipated use during the study.